脑部放疗,上午比下午敏感许多!* j9 k* b) T: O9 W
9 S6 X* w X+ |
( u# k* P4 C0 W6 ^( m
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.8 J: s3 Q3 u: ?' R) m) w' m* w5 T
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
; |. A! W" G* u, n) y( n& @( g2 ?) oRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
/ D0 k9 u1 L4 z- E# X, k0 USourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
% A& e5 g! k* T# o' Y- L' E. k( K
% F- Z/ x% i: @# g% x, i) \Abstract s" U+ P( X9 h/ _5 @ I
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
* x. i# O- P1 F4 ^! r. Y2 J* f R
# j( ]9 x" z' ]9 b/ m0 _ xMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
4 k+ p" S' U/ q1 m
" s0 \8 c, k" b/ {RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).* x' a! b" L3 p# ^1 z% Z
) l. v" t& G+ `% T* V7 W: VCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.2 E; @) H$ e: q; S4 w6 U
/ F# G8 F4 F2 h4 h+ S9 C/ X |